🔎 Trials Near Me

Domov › Alzheimerjeva bolezen › Ohio

Klinične študije za Alzheimerjeva bolezen v Ohio

17 študij za Alzheimerjeva bolezen išče udeležence na lokacijah v Ohio.

Mesta v Ohio

Uradno besedilo študije (angleško)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Dayton
  • Clinical Site, Independence
Vključevanje udeležencevFaza 2
Starost 55–90 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06887192

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 2617, Blue Ash
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06937229

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Local Institution - 1265, Cleveland
  • Ohio State University, Columbus
  • Local Institution - 1258, Dayton
  • in še 1
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06585787

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

  • NDx Clinical Research, Dayton
Vključevanje udeležencevFaza 2
Starost 55–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Ohio State University, Columbus
Vključevanje udeležencevFaza 3
Starost 50–90 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07177352

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • Velocity Clinical Research - Blue Ash, Blue Ash
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07011745

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • Cleveland Clinic, Cleveland
  • Local Institution - 0087, Columbus
Vključevanje udeležencevFaza 2
Starost 55–90 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • Insight Clinical Trials ( Site 1011), Independence
  • Neuro-Behavioral Clinical Research ( Site 1028), North Canton
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07033494

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • Ohio State University, Columbus
  • NDx Clinical Research Inc., Dayton
Vključevanje udeležencevFaza 3
Starost 60–85 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06976216

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06563895

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • NDx Clinical Research, Inc., Dayton
  • Care Access - Lima, Lima
Vključevanje udeležencevFaza 3
Starost 55 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07602582

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

  • Local Institution - 0029, Cleveland
  • Insight Clinical Trials LLC - Independence, Independence
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 30. jun. 2026 · NCT06947941

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • The Ohio State University, Columbus
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT07094516

[18F]PI-2620 Phase 3 Histopathological Study

  • Insight Clinical Trials LLC, Beachwood
  • Valley Medical Research, Centerville
Vključevanje udeležencevFaza 3
Starost 50 in več · Vsi spoli · Posodobljeno 22. maj 2026 · NCT05641688

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • Case Western Reserve University, Beachwood
  • University of Cincinnati, Cincinnati
Vključevanje udeležencevOpazovalna študija
Starost 25–55 · Vsi spoli · Posodobljeno 18. maj 2026 · NCT04165109

Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's

  • Ohio University, Athens
  • The Ohio State University, Columbus
Vključevanje udeležencev
Starost 60 in več · Vsi spoli · Posodobljeno 5. mar. 2026 · NCT05748613

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • The Ohio State University, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 30. mar. 2025 · NCT03019757

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.